The Clinical Case for providing stop smoking …

Community pharmacy personnel interventions for …

[Intervention Review] Community pharmacy personnel interventions for smoking cessation Hazel K Sinclair 1, Christine M Bond , Lindsay F Stead2 1Department of General Practice and Primary Care, University of Aberdeen, Aberdeen, UK. 2Department of Primary Health Care,

  Interventions, Personnel, Community, Pharmacy, Community pharmacy personnel interventions for

PHI001 smoking cessation

NICE public health intervention guidance – Brief interventions and referral for smoking cessation in primary care and other settings Page 2 of 36 Foreword

  Smoking, Cessation, Smoking cessation, Phi001 smoking cessation, Phi001

e-cigarettes briefing [ 2 ] v4 - NCSCT

Electronic cigarettes: A briefing for stop smoking services 03 Contents Introduction 04 Background 05 E-cigarettes and stop smoking services 07 Recommendations for practice 13 Regulation 15 Summary of evidence on e-cigarettes 17 Prevalence and epidemiology 19 Why are people using e-cigarettes? 22

  Briefing, E cigarettes briefing, Cigarettes

Assessing smoking cessation performance in NHS …

Russell Standard (Clinical) Page 1 Assessing smoking cessation performance in NHS Stop Smoking Services: The Russell Standard (Clinical) Robert West

  Performance, Assessing, Assessing smoking cessation performance in, Smoking, Cessation

Workplace health promotion: how to help …

1 Issue Date: April 2007 Workplace health promotion: how to help employees to stop smoking Public health intervention guidance 5

  Health, Employee, Help, Workplace, Promotion, Workplace health promotion, How to help, How to help employees

Service and delivery guidance 2014 - National …

Service and delivery guidance 2014 Local Stop Smoking Services Service and delivery guidance 2014

  Services, Guidance, Delivery, 2014, Smoking, Service and delivery guidance 2014

PDF not for circulation Smoking and mental health …

Smoking and mental health 5.5 Provision of smoking cessation and tobacco dependence treatment for smokers with mental disorders in the UK 96 5.5.1 …

  Health, Mental, Smoking, Smoking and mental health

Stead LF, Perera R, Bullen C, Mant D, Lancaster T

Main results We identified 132 trials; 111 with over 40,000 participants contributed to the primary comparison between any type of NRT and a placebo or non-NRT control group.

Smoking Cessation and Mental Health

Smoking Cessation and Mental Health www.ncsct.co.uk 3 Background information Smoking prevalence Currently in the UK, approximately 20% of adults smoke.

  Health, Mental, Smoking, Cessation, Smoking cessation and mental health

behaviour (lifestyle) services: a review of the evidence

4 Integrated health behaviour (lifestyle) services: a review of the evidence 1. Executive Summary Health behaviours that put people at risk of …

  Review, Evidence, Integrated, A review of the evidence

Primary Care Stop Smoking Pharmacotherapy …

Primary Care Stop Smoking Pharmacotherapy Prescribing Summary 27.09.13 1 This summary is taken from the BNF edition 65.It is …

  Primary, Care, Post, Summary, Prescribing, Smoking, Pharmacotherapy, Primary care stop smoking pharmacotherapy, Primary care stop smoking pharmacotherapy prescribing summary

Local Stop Smoking Services - National Centre for …

This set out a number of changes to the public health system, including moving Directors of Public Health and public health funding from primary care trusts (PCTs) in the NHS to local authorities by April 2013, and the setting

  Primary, Care, Post, Primary care, Smoking, Stop smoking

Pharmacy-based stop smoking services ... - NHS …

4 Smoking is the single greatest cause of preventable morbidity and premature deaths in England, with half a million hospital admissions of adults aged over 35 attributed to smoking.

  Services, Based, Post, Pharmacy, Smoking, Pharmacy based stop smoking services

Chronic Kidney Disease (CKD) Management in

6 CKD and cardiovascular disease 7 Absolute cardiovascular risk assessment 7 Reducing cardiovascular risk - lifestyle modification 10 Reducing cardiovascular risk - pharmacotherapy 10

  Pharmacotherapy

MANAGEMENT OF RAYNAUD’S PHENOMENON

1 MANAGEMENT OF RAYNAUD’S PHENOMENON 1. Establish diagnosis and identify any underlying cause amenable to treatment (1) Establish whether primary or secondary

  Primary